Lothar Krinke, Ph.D., is the CEO of Welcony, the global neurotechnology leader that supports thousands of research labs, clinics, hospitals, and universities that focus on mental health, brain disorders, cognitive neuroscience, and neuromonitoring. Welcony’s Inspired Neurotechnology is changing lives worldwide, and Dr. Krinke’s passion is to help improve patient outcomes.
Led by Dr. Lothar Krinke, Welcony brands include Magstim Magnetic Stimulation, Magstim EGI high-density EEG, Technomed Clinical Neurophysiology, and Neurosign Nerve Safety Monitoring. Prior to leading Welcony, Dr. Krinke was the Vice President & General Manager of the Medtronic Brain Modulation (DBS) business. He is an Adjunct Assistant Professor position in Neuroscience at West Virginia University.
“Neuroscience innovations offer a new level of patient and treatment insights that help physicians and clinicians in their life-saving work,” said Dr. Krinke. “Our combined strength leads to great solutions, and we all contribute to the quality and success of Welcony.”
Globally, Welcony technologies have supported thousands of research labs, clinics, hospitals and universities that focus on mental health, brain disorders, cognitive neuroscience and neuromonitoring. Key brands and technologies include: Magstim – Transcranial Magnetic Stimulation (TMS) MagstimEGI – High-Density EEG Technomed – Clinical Neurophysiology Neurosign – Nerve Integrity Monitoring
